600557 康缘药业
已收盘 08-05 15:00:00
资讯
新帖
简况
股市必读：康缘药业新发布《江苏康缘药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 08-05 02:34
股市必读：康缘药业新发布《江苏康缘药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告》
康缘药业新注册《浓缩工序工艺参数预测系统V1.0》项目的软件著作权
证券之星 · 07-29
康缘药业新注册《浓缩工序工艺参数预测系统V1.0》项目的软件著作权
康缘药业(600557.SH)：芪黄正气颗粒获批开展临床试验
智通财经 · 07-21
康缘药业(600557.SH)：芪黄正气颗粒获批开展临床试验
股市必读：康缘药业（600557）7月17日收盘跌5.72%，主力净流出406.21万元
证券之星 · 07-20
股市必读：康缘药业（600557）7月17日收盘跌5.72%，主力净流出406.21万元
每周股票复盘：康缘药业（600557）首次回购58.41万股耗资787.76万元
证券之星 · 07-19
每周股票复盘：康缘药业（600557）首次回购58.41万股耗资787.76万元
康缘药业（600557）披露以集中竞价交易方式首次回购公司股份公告，7月16日股价上涨2.64%
证券之星 · 07-16
康缘药业（600557）披露以集中竞价交易方式首次回购公司股份公告，7月16日股价上涨2.64%
每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录
证券之星 · 07-12
每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录
股市必读：康缘药业（600557）7月8日董秘有最新回复
证券之星 · 07-09
股市必读：康缘药业（600557）7月8日董秘有最新回复
股市必读：康缘药业（600557）7月3日董秘有最新回复
证券之星 · 07-06
股市必读：康缘药业（600557）7月3日董秘有最新回复
每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元
证券之星 · 07-05
每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元
康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%
证券之星 · 07-03
康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%
康缘药业：截至6月30日公司尚未实施回购股份
证券日报网 · 07-03
康缘药业：截至6月30日公司尚未实施回购股份
康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组
证券之星 · 07-03
康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组
康缘药业：公司目前未持有GAP认证基地
证券之星 · 06-29
康缘药业：公司目前未持有GAP认证基地
6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股
证券之星 · 06-29
6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股
异动快报：康缘药业（600557）6月29日10点21分触及涨停板
证券之星 · 06-29
异动快报：康缘药业（600557）6月29日10点21分触及涨停板
每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份
证券之星 · 06-28
每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份
康缘药业(600557.SH)获得一贯煎颗粒药品注册证书
智通财经 · 06-26
康缘药业(600557.SH)获得一贯煎颗粒药品注册证书
康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%
证券之星 · 06-22
康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%
股市必读：康缘药业（600557）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：康缘药业（600557）6月1日董秘有最新回复
加载更多
公司概况
公司名称：
江苏康缘药业股份有限公司
所属行业：
医药制造业
上市日期：
2002-09-18
主营业务：
江苏康缘药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是注射类产品、口服类产品、外用类产品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业，全国制药工业百强企业。
发行价格：
7.00
{"stockData":{"symbol":"600557","market":"SH","secType":"STK","nameCN":"康缘药业","latestPrice":12.57,"timestamp":1785913201000,"preClose":12.82,"halted":0,"volume":10020240,"delay":0,"changeRate":-0.0195,"floatShares":566000000,"shares":566000000,"eps":0.5296,"marketStatus":"已收盘","change":-0.25,"latestTime":"08-05 15:00:00","open":12.83,"high":12.83,"low":12.47,"amount":126000000,"amplitude":0.0281,"askPrice":12.57,"askSize":7,"bidPrice":12.56,"bidSize":713,"shortable":0,"etf":0,"ttmEps":0.5296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785979800000},"marketStatusCode":5,"adr":0,"adjPreClose":12.82,"symbolType":"stock","openAndCloseTimeList":[[1785893400000,1785900600000],[1785906000000,1785913200000]],"highLimit":14.1,"lowLimit":11.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":566158806,"isCdr":false,"pbRate":1.45,"roa":"--","peRate":23.734894,"roe":"1.63%","epsLYR":0.54,"committee":0.71397,"marketValue":7117000000,"turnoverRate":0.0177,"status":1,"floatMarketCap":7117000000},"requestUrl":"/m/hq/s/600557","defaultTab":"news","newsList":[{"id":"2657565309","title":"股市必读：康缘药业新发布《江苏康缘药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565309?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:34","pubTimestamp":1785868452,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏康缘药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告江苏康缘药业股份有限公司于2026年4月22日及6月26日审议通过回购股份方案，拟以集中竞价交易方式回购股份，资金总额为1亿元至2亿元，回购价格不超过20.9元/股，回购期限为2026年6月26日至2027年6月25日，回购股份将用于减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884967","title":"康缘药业新注册《浓缩工序工艺参数预测系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655884967?lang=zh_cn&edition=full","pubTime":"2026-07-29 02:23","pubTimestamp":1785262993,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康缘药业（600557）新注册了《浓缩工序工艺参数预测系统V1.0》项目的软件著作权。今年以来康缘药业新注册软件著作权10个，较去年同期增加了25%。结合公司2025年年报财务数据，2025年公司在研发方面投入了6.08亿元，同比减4.78%。通过天眼查大数据分析，江苏康缘药业股份有限公司共对外投资了19家企业，参与招投标项目7273次；财产线索方面有商标信息519条，专利信息1055条，著作权信息52条；此外企业还拥有行政许可871个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900001513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159180","BK0188","BK0239","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653200682","title":"康缘药业(600557.SH)：芪黄正气颗粒获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2653200682","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653200682?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:55","pubTimestamp":1784624135,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康缘药业 发布公告，公司近日收到国家药品监督管理局签发的芪黄正气颗粒《药物临床试验批准通知书》，同意本品开展用于癌因性疲乏的临床试验。芪黄正气颗粒为中医理论指导下形成的临床经验方，具有益气养血，扶正补虚的功效。毒理学研究结果显示，芪黄正气颗粒单次给药、重复给药毒性试验动物未见严重不良反应，耐受性良好，具有较好安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","BMED","MDTX","IBBJ","BK0028","BK0239","600557","BK0188","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652566257","title":"股市必读：康缘药业（600557）7月17日收盘跌5.72%，主力净流出406.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652566257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652566257?lang=zh_cn&edition=full","pubTime":"2026-07-20 02:09","pubTimestamp":1784484549,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，康缘药业报收于12.85元，下跌5.72%，换手率2.83%，成交量16.02万手，成交额2.1亿元。当日关注点交易信息汇总：康缘药业7月17日收盘价12.85元，单日下跌5.72%，成交额2.1亿元。公司公告汇总：康缘药业于7月16日首次以集中竞价方式回购股份584,100股，占总股本0.1032%，支付金额787.76万元，回购股份将用于减少注册资本并注销。前10个交易日主力资金累计净流入633.06万元，股价累计下跌5.72%；融资余额累计减少182.14万元，融券余量累计增加4900股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600557","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652307552","title":"每周股票复盘：康缘药业（600557）首次回购58.41万股耗资787.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652307552","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652307552?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:06","pubTimestamp":1784401572,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，康缘药业报收于12.85元，较上周的12.4元上涨3.63%。本周，康缘药业7月16日盘中最高价报13.77元。康缘药业当前最新总市值72.75亿元，在中药板块市值排名28/66，在两市A股市值排名2227/5199。本周关注点公司公告汇总：首次回购584,100股，耗资787.76万元公司公告汇总江苏康缘药业股份有限公司于2026年7月16日通过上海证券交易所集中竞价交易方式首次回购股份584,100股，占公司总股本的0.1032%。本次回购符合相关法规及公司回购方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651440297","title":"康缘药业（600557）披露以集中竞价交易方式首次回购公司股份公告，7月16日股价上涨2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651440297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651440297?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:17","pubTimestamp":1784211436,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，康缘药业报收于13.63元，较前一交易日上涨2.64%，最新总市值为77.17亿元。该股当日开盘13.03元，最高13.77元，最低12.95元，成交额达2.76亿元，换手率为3.63%。近日，江苏康缘药业股份有限公司发布《关于以集中竞价交易方式首次回购公司股份的公告》。回购资金总额预计为1亿元至2亿元，回购价格不超过20.9元/股，回购期限为2026年6月26日至2027年6月25日，回购股份用于减少注册资本，完成后将予以注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600557","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154911","title":"每周股票复盘：康缘药业（600557）51个产品纳入国家基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154911","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154911?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:35","pubTimestamp":1783794911,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，康缘药业报收于12.4元，较上周的12.72元下跌2.52%。本周，康缘药业7月6日盘中最高价报12.85元。本周关注点来自公司公告汇总：51个产品纳入《国家基本药物目录》，其中8个为新增纳入。江苏康缘药业股份有限公司共有51个产品纳入该目录，其中8个药品新增纳入，包括散结镇痛胶囊、清热解毒口服液、小柴胡颗粒、恩格列净片等，原43个品种继续保留，无产品退出。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600557","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650891881","title":"股市必读：康缘药业（600557）7月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2650891881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650891881?lang=zh_cn&edition=full","pubTime":"2026-07-09 01:37","pubTimestamp":1783532229,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，康缘药业报收于12.5元，上涨4.25%，换手率2.29%，成交量12.94万手，成交额1.61亿元。董秘最新回复投资者： 董秘您好，我是一名税务专家，我注意到：贵公司过去五年加总的实际所得税率位于行业最低10%。税务问题的专业性强，复杂度高，对企业发展至关重要。当日关注点交易信息汇总：7月8日主力资金净流入631.47万元，游资资金净流入133.88万元，散户资金净流出765.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","600557","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649843619","title":"股市必读：康缘药业（600557）7月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649843619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649843619?lang=zh_cn&edition=full","pubTime":"2026-07-06 03:20","pubTimestamp":1783279222,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，上涨0.87%，换手率1.72%，成交量9.76万手，成交额1.23亿元。公司公告汇总：康缘药业回购股份方案已获董事会及年度股东会审议通过，回购资金总额为1亿至2亿元、价格上限20.9元/股、期限至2027年6月25日；截至6月30日尚未实施回购。回购股份将用于减少注册资本，并在回购完成后予以注销。公司将根据市场情况择机实施回购，并按规定履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600001159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600557","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692342","title":"每周股票复盘：康缘药业（600557）拟回购股份总额不低于1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692342","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692342?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:18","pubTimestamp":1783192693,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，较上周的10.87元上涨17.02%。本周，康缘药业7月3日盘中最高价报12.81元。本周关注点公司公告汇总：康缘药业拟以不低于1亿元且不超过2亿元资金回购股份，价格不超20.9元/股。公司公告汇总江苏康缘药业股份有限公司于2026年4月22日及6月26日召开董事会及年度股东会，审议通过以集中竞价交易方式回购公司股份的方案。截至2026年6月30日，公司尚未实施回购股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600557","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648617366","title":"康缘药业（600557）披露以集中竞价交易方式回购公司股份的进展公告，7月3日股价上涨0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648617366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648617366?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:39","pubTimestamp":1783089557,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康缘药业报收于12.72元，较前一交易日上涨0.87%，最新总市值为72.02亿元。近日，江苏康缘药业股份有限公司发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示，公司于2026年4月22日及6月26日召开董事会及年度股东会，审议通过以集中竞价交易方式回购公司股份的方案。回购股份将用于减少注册资本，并在回购完成后予以注销。截至2026年6月30日，公司尚未实施回购股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648177669","title":"康缘药业：截至6月30日公司尚未实施回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2648177669","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648177669?lang=zh_cn&edition=full","pubTime":"2026-07-03 20:32","pubTimestamp":1783081920,"startTime":"0","endTime":"0","summary":"证券日报网讯 7月3日，康缘药业发布公告称，截至2026年6月30日，公司尚未实施回购股份，公司后续将根据市场情况择机实施本次回购方案。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-03/doc-inifpuss2411223.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-03/doc-inifpuss2411223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600557","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648020652","title":"康缘药业：ZX2021注射液、ZX2010注射液临床II期均已完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2648020652","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648020652?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:57","pubTimestamp":1783069055,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业(600557)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司的两种靶向生物减肥药的临床二期什么时候结束，实验的效果如何，三期何时展开？康缘药业回复：尊敬的投资者，您好！公司研发管线稳步推进中，生物创新药ZX2021注射液、ZX2010注射液目前临床II期均已完成受试者入组，计划在现有剂量安全性、可靠性良好的基础上进行更高剂量探索。对于上述药品临床试验进展、审评审批结果等关键信息，公司会按照相关法律法规的要求及时履行信息披露义务。感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300030641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647207023","title":"康缘药业：公司目前未持有GAP认证基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2647207023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647207023?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:54","pubTimestamp":1782726885,"startTime":"0","endTime":"0","summary":"证券之星消息，康缘药业(600557)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！公司现有通过GAP认证基地多少亩？康缘药业回复：尊敬的投资者，您好！公司主要业务涉及药品的研发、生产与销售，目前未持有GAP认证基地。公司构建规范、专业、高效的招标采购管理体系，确保相关药材源自符合国家GAP标准的规范化种植基地。同时，公司进一步优化生产质量管控体系，确保原料、中间体和成品批次间质量稳定、均一，从生产环节切实保障药品安全有效、稳定可控。谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647032419","title":"6月29日康缘药业涨10.03%，方正富邦鑫诚12个月持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647032419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647032419?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:29","pubTimestamp":1782721775,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日康缘药业涨10.03%创60日新低，收盘报11.96元，换手率1.64%，成交量9.27万手，成交额1.07亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为方正富邦基金的方正富邦鑫诚12个月持有混合A。方正富邦鑫诚12个月持有混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600557","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342096","title":"异动快报：康缘药业（600557）6月29日10点21分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647342096?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:25","pubTimestamp":1782699930,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点21分康缘药业（600557）触及涨停板。其所属行业中药目前上涨。领涨股为太龙药业。该股为创新药，医药，阿尔茨海默病概念热股，当日创新药概念上涨5.33%，医药概念上涨3.5%，阿尔茨海默病概念上涨3.04%。6月26日的资金流向数据方面，主力资金净流出568.94万元，占总成交额9.63%，游资资金净流出137.44万元，占总成交额2.33%，散户资金净流入706.38万元，占总成交额11.95%。近5日资金流向一览见下表：康缘药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900008460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600557","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315802","title":"每周股票复盘：康缘药业（600557）推1至2亿回购并注销股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646315802?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:06","pubTimestamp":1782587174,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，康缘药业报收于10.87元，较上周的11.83元下跌8.11%。本周，康缘药业6月23日盘中最高价报12.09元。江苏世纪同仁律师事务所确认，康缘药业2025年年度股东会的召集、召开程序、出席人员资格、表决程序及结果合法有效。康缘药业于2026年6月26日召开2025年年度股东会，出席会议股东及代理人共453人，代表有表决权股份256,490,723股，占总股本的45.3037%。回购股份将全部用于减少注册资本并注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600557","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646351617","title":"康缘药业(600557.SH)获得一贯煎颗粒药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2646351617","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646351617?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:05","pubTimestamp":1782471932,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康缘药业(600557.SH)发布公告，公司于近日收到国家药品监督管理局签发的一贯煎颗粒《药品注册证书》。功能主治：滋阴疏肝。用于肝阴不足，血燥气郁证。症见胸脘胁痛，吞酸吐苦，咽干口燥，舌红少津，脉细弦。亦治疝气瘕聚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","600557","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073406","title":"康缘药业（600557）披露前十大股东持股情况，6月22日股价下跌1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645073406?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:38","pubTimestamp":1782139103,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，康缘药业报收于11.6元，较前一交易日下跌1.94%，最新总市值为65.67亿元。该股当日开盘11.78元，最高11.78元，最低11.29元，成交额达6179.17万元，换手率为0.95%。公告显示，截至2026年6月17日股东会股权登记日，公司前十大股东及前十大无限售条件股东的持股情况。其中，江苏康缘集团有限责任公司持股176,173,467股，占比31.12%，为第一大股东。连云港康贝尔医疗器械有限公司、肖伟等位列其后。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600557","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969870","title":"股市必读：康缘药业（600557）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640969870?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:09","pubTimestamp":1780337354,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，康缘药业报收于12.86元，下跌0.39%，换手率0.79%，成交量4.47万手，成交额5740.72万元。董秘最新回复投资者： 公司应当向同城的恒瑞和豪森学习，逐步收缩中药业务，向化学药和生物药倾斜，另外，请贵司说明，为什么中新医药合并报表后研发费用反而不见增加，是不是研发费用这一项目有什么会计上的特殊处理方法？现阶段中药业务仍然是公司主营业务和现金流，确保公司运营和研发投入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600557","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785974219989,"stockEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0016},{"period":"3month","weight":-0.0647},{"period":"6month","weight":-0.1512},{"period":"1year","weight":-0.2954},{"period":"ytd","weight":-0.1091}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":-0.0403},{"period":"3month","weight":-0.0722},{"period":"6month","weight":-0.046},{"period":"1year","weight":0.0721},{"period":"ytd","weight":-0.0228}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康缘药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42174人(较上一季度减少1.33%)","perCapita":"13424股","listingDate":"2002-09-18","address":"江苏省连云港市连云区经济技术开发区江宁工业城","registeredCapital":"56615万元","survey":" 江苏康缘药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是注射类产品、口服类产品、外用类产品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业，全国制药工业百强企业。","listedPrice":7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康缘药业,600557,康缘药业股票,康缘药业股票老虎,康缘药业股票老虎国际,康缘药业行情,康缘药业股票行情,康缘药业股价,康缘药业股市,康缘药业股票价格,康缘药业股票交易,康缘药业股票购买,康缘药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}